The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer Institute

Interventions designed to limit the spread of coronavirus disease 2019 (COVID-19) are having profound effects on the delivery of health care, but data showing the impact on oncology clinical trial enrollment, treatment, and monitoring are limited. We prospectively tracked relevant data from oncology...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Natl Cancer Inst
Main Authors: Tolaney, Sara M, Lydon, Christine A, Li, Tianyu, Dai, Jiale, Standring, Andrea, Legor, Kristen A, Caparrotta, Caryn M, Schenker, Matthew P, Glazer, Daniel I, Tayob, Nabihah, DuBois, Steven G, Meyerhardt, Jeffrey A, Taplin, Mary-Ellen, Johnson, Bruce E
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Commentaries
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7543498/
https://ncbi.nlm.nih.gov/pubmed/32959883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djaa144
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados